Cargando…
Diabetic ketoacidosis following PEG-asparaginase therapy
We report a case of a 21-year-old African American female with history of pre-diabetes, and a diagnosis of a rare leukemia, blastic-plasmacytoid dendritic neoplasm (BPDCN), who developed diabetic ketoacidosis (DKA) after the third dose of PEG-asparaginase infusion. She was successfully treated with...
Autores principales: | Ahmad, Miriam Hinaa, Shafiq, Ismat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215938/ https://www.ncbi.nlm.nih.gov/pubmed/30427164 http://dx.doi.org/10.1530/EDM-18-0064 |
Ejemplares similares
-
Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism
por: Patel, Shivani, et al.
Publicado: (2019) -
Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis
por: Tzoulis, Ploutarchos, et al.
Publicado: (2018) -
Diabetic ketoacidosis after the treatment of anaphylaxis
por: Brenner, Daniel S, et al.
Publicado: (2022) -
Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis
por: Rafey, Mohammed Faraz, et al.
Publicado: (2019) -
Presentation of new onset type 1 diabetes with diabetic ketoacidosis and hyperosmolar hyperglycaemia after a single dose of nivolumab and ipilimumab
por: Stathi, Dimitra, et al.
Publicado: (2023)